Stock Events

Stock Events

HeartSciences 

$4.03
35
-$0.40-9.03% 16:11 Today

Statistics

Day High
4.48
Day Low
3.97
52W High
5.25
52W Low
1.63
Volume
546,320
Avg. Volume
-
Mkt Cap
19.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10DecExpected
Q4 2024
Q2 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
Next
-2.55
-1.9
-1.26
-0.62
Expected EPS
-0.62
Actual EPS
N/A

Financials

-228,550%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4,000Revenue
-9.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSCS. It's not an investment recommendation.
Apple
5
AAPL
Realty Income
5
O
Palantir Technologies
5
PLTR
Microvast
5
MVST

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap175.27B
Abbott Laboratories offers a broad range of cardiovascular devices and diagnostics, directly competing with HSCS's heart testing technologies.
Medtronic
MDT
Mkt Cap113.38B
Medtronic plc specializes in medical devices for cardiac and vascular diseases, offering products that compete with HSCS's heart diagnostic solutions.
Boston Scientific
BSX
Mkt Cap63.65B
Boston Scientific Corporation provides innovative medical solutions, including cardiovascular devices that compete with HSCS's offerings.
Johnson & Johnson
JNJ
Mkt Cap653.61B
Johnson & Johnson, through its medical device segment, offers products for cardiovascular care, competing with HSCS's heart diagnostics.
Koninklijke Philips N.V.
PHG
Mkt Cap24.4B
Royal Philips offers advanced cardiac diagnostics and monitoring solutions, competing with HSCS in the heart test market.
GE Aerospace
GE
Mkt Cap339.38B
General Electric, through its healthcare division, provides medical imaging and monitoring technologies for cardiovascular care, competing with HSCS.
Siemens
SIEGY
Mkt Cap239.92B
Siemens Healthineers offers a wide range of diagnostic imaging and laboratory diagnostics, including cardiovascular testing, competing with HSCS.
Baxter International
BAX
Mkt Cap12.08B
Baxter International Inc. provides a range of medical devices and software for health care, including products for cardiovascular support, competing with HSCS.
Becton Dickinson
BDX
Mkt Cap50.07B
Becton, Dickinson and Company offers medical devices and technology, including for cardiovascular care, competing with HSCS's heart diagnostics.

About

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
Show more...
CEO
Andrew Simpson
Employees
14
Country
United States
ISIN
US42254E3027

Listings

XNAS
US
HSCSW
XNAS
US
HSCS
BOATS
BOATS
HSCS.BOATS

0 Comments

Share your thoughts

FAQ

What is HeartSciences stock price today?▼
The current price of HSCS is $4.03 USD — it has decreased by -9.03% in the past 24 hours. Watch HeartSciences stock price performance more closely on the chart.
What is HeartSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange HeartSciences stocks are traded under the ticker HSCS.
Is HeartSciences stock price growing?▼
HSCS stock has fallen by -11.28% compared to the previous week, the month change is a +34.98% rise, over the last year HeartSciences has showed a +19.59% increase.
What is HeartSciences market cap?▼
Today HeartSciences has the market capitalization of 19.34M
When is the next HeartSciences earnings date?▼
HeartSciences is going to release the next earnings report on December 10, 2026.
What were HeartSciences earnings last quarter?▼
HSCS earnings for the last quarter are -0.86 USD per share, whereas the estimation was -0.72 USD resulting in a -19.44% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HeartSciences revenue for the last year?▼
HeartSciences revenue for the last year amounts to 4,000 USD.
What is HeartSciences net income for the last year?▼
HSCS net income for the last year is -9.14M USD.
How many employees does HeartSciences have?▼
As of September 29, 2026, the company has 14 employees.
In which sector is HeartSciences located?▼
HeartSciences operates in the Health & Wellness sector.
When did HeartSciences complete a stock split?▼
The last stock split for HeartSciences was on May 17, 2024 with a ratio of 1:100.
Where is HeartSciences headquartered?▼
HeartSciences is headquartered in SOUTHLAKE, United States.